Cargando…
CD70 in Thymic Squamous Cell Carcinoma: Potential Diagnostic Markers and Immunotherapeutic Targets
CD70 – a ligand protein of CD27 on lymphocytes – is expressed in a large spectrum of malignancies. It is an attractive target for antibody-based therapy and several clinical trials are currently being conducted. However, there is no evidence regarding the expression of CD70 and its relationship with...
Autores principales: | Kashima, Jumpei, Hishima, Tsunekazu, Okuma, Yusuke, Horio, Hirotoshi, Ogawa, Masumi, Hayashi, Yukiko, Horiguchi, Shin-ichiro, Motoi, Toru, Ushiku, Tetsuo, Fukayama, Masashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821901/ https://www.ncbi.nlm.nih.gov/pubmed/35145909 http://dx.doi.org/10.3389/fonc.2021.808396 |
Ejemplares similares
-
Osseous oligometastases from thymic carcinoma: a case report suggesting the effectiveness of palliative-intent radiotherapy treatment
por: Kashima, Jumpei, et al.
Publicado: (2016) -
Genetic and immunohistochemical analyses of ciliated muconodular papillary tumors of the lung: A report of five cases
por: Kashima, Jumpei, et al.
Publicado: (2019) -
A patient previously treated with ALK inhibitors for central nervous system lesions from ALK rearranged lung cancer: a case report
por: Kashima, Jumpei, et al.
Publicado: (2016) -
Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center
por: Okuma, Yusuke, et al.
Publicado: (2014) -
Extraosseous Benign Notochordal Cell Tumor Originating in the Lung: A Case Report
por: Takahashi, Yusuke, et al.
Publicado: (2015)